Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Correction

Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer

Authors: Xiaojun Man, Chiyuan Piao, Xuyong Lin, Chuize Kong, Xiaolu Cui, Yuanjun Jiang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Correction to: J Exp Clin Cancer Res 38, 259 (2019) …

Man X, Piao C, Lin X, et al. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J Exp Clin Cancer Res. 2019;38:259. https://doi.org/10.1186/s13046-019-1262-4.CrossRefPubMedPubMedCentral

Title: Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer
Authors: Xiaojun Man
Chiyuan Piao
Xuyong Lin
Chuize Kong
Xiaolu Cui
Yuanjun Jiang
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-02194-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway

Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex

Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention

Correction to: Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer

N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies

Keynote webinar | Spotlight on antibody–drug conjugates in cancer